Latest filing published 20 Nov 2014 for Concert Pharmaceuticals, INC., €2.4M.
No signal scores available.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Three Arch Management IV, L.L.C. has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Talphera, Inc., Concert Pharmaceuticals, Inc. and Nevro Corp. The record holds 32 filings, for trades running from 18 January 2008 to 18 November 2014.
Market trades split into 4 purchases (€5.8M) and 2 sales (€2.5M). Taken together, the purchases exceed the sales by €3.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants. So far in 2014, the count stands at 2 purchases and 2 sales.
The median purchase comes to €567k.
The latest filing, published on 20 November 2014, reports an open-market sale of €53k in Concert Pharmaceuticals, Inc. The last purchase on record was published on 21 February 2014, which is 4,628 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 32 declarations